Zoetis Stock Slips as KeyBanc Initiates with 'Sector Weight'
KeyBanc initiated coverage of Zoetis Inc. (NYSE:ZTS) with a Sector Weight rating on November 20, 2025. The rating suggests an expectation that the stock will perform in line with its sector peers. On that day, the animal health company's stock price decreased by 1.02%, or $1.19, to $115.89.
The day's trading saw ZTS shares move between $115.80 and $118.43, with a total volume of 3,260,584. Over the past year, the stock has recorded a high of $181.85 and a low of $115.25. The company's market capitalization stands at approximately $51.07 billion.
In upcoming events, Zoetis is set to participate in the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025. CEO Kristin Peck and CFO Wetteny Joseph will represent the company, addressing analyst questions on strategy and performance. A live webcast will be available on the Zoetis investor website.
Zoetis is a global developer and manufacturer of veterinary vaccines and medicines. It serves veterinarians, livestock producers, and pet owners, competing with major industry players like Elanco Animal Health and Merck Animal Health. More details on the company's history and ownership and its financial health are available.
Zoetis Inc. (ZTS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.